Reuters logo
BRIEF-Cadila Healthcare says Zydus announces settlement with Supernus on Trokendi XR extended-release capsules
March 7, 2017 / 5:45 AM / 9 months ago

BRIEF-Cadila Healthcare says Zydus announces settlement with Supernus on Trokendi XR extended-release capsules

March 7 (Reuters) - Cadila Healthcare Ltd

* Says Zydus announces settlement with Supernus on Trokendi XR® (Topiramate) extended-release capsules

* Says Supernus grants Zydus license to market Zydus generic version of Trokendi XR extnded release capsules from Jan 1 2023

* Says Zydus finalised agreement with Supernus Pharma to settle outstanding patent litigation related to Trokendi XR capsules

* Other terms of settlement not disclosed Source text - (bit.ly/2n8QXNo) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below